Edition:
United States

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

4.69USD
27 Jul 2016
Change (% chg)

-- (--)
Prev Close
$4.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,971
52-wk High
$6.45
52-wk Low
$4.20

CPIX.OQ

Chart for CPIX.OQ

About

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcyste... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $76.08
Shares Outstanding(Mil.): 16.22
Dividend: --
Yield (%): --

Financials

  CPIX.OQ Industry Sector
P/E (TTM): 188.88 35.76 36.62
EPS (TTM): 0.02 -- --
ROI: 0.47 15.33 14.52
ROE: 0.56 16.37 15.68

BRIEF-Cumberland Pharmaceuticals says Caroline Young to join its board

* Cumberland Pharmaceuticals announces Caroline Young to join its board of directors Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 10 2016

BRIEF-Cumberland Pharmaceuticals Q1 adjusted earnings per share $0.02

* Cumberland Pharmaceuticals Inc says as of march 31, 2016, company had just under $90 million in total assets including over $51 million in cash and marketable securities

May 10 2016

BRIEF-Clinigen, Cumberland enter into U.S. commercialisation deal for ethyol

* Co and Cumberland Pharmaceuticals enter into exclusive u.s. Commercialisation agreement for oncology support drug ethyol Source text for Eikon: Further company coverage:

May 10 2016

BRIEF-Cumberland Pharmaceuticals announces new program to develop Vasculan

* Cumberland Pharmaceuticals announces new program to develop Vasculan for systemic sclerosis

Apr 27 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.